Holen Sie sich die Stockscreener-App
14.95
0.60%
-0.09
Vorhandelsmarkt:
15.00
0.05
+0.33%
Schlusskurs vom Vortag:
$15.04
Offen:
$14.88
24-Stunden-Volumen:
1.66M
Relative Volume:
0.54
Marktkapitalisierung:
$3.85B
Einnahmen:
$6.41B
Nettoeinkommen (Verlust:
$1.30B
KGV:
2.9663
EPS:
5.04
Netto-Cashflow:
$646.00M
1W Leistung:
+0.07%
1M Leistung:
-5.68%
6M Leistung:
-25.81%
1J Leistung:
-8.73%
1-Tages-Spanne:
$14.83
$15.00
1-Wochen-Bereich:
$14.53
$15.41
52-Wochen-Spanne:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Vergleichen Sie OGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
14.95 | 3.85B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
865.00 | 822.10B | 45.04B | 10.59B | -2.28B | 11.71 |
|
NVO
Novo Nordisk Adr
|
83.74 | 371.73B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
156.13 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
191.83 | 338.99B | 56.33B | 4.28B | 15.62B | 2.40 |
|
MRK
Merck Co Inc
|
86.54 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Organon & Co. (OGN) to Release Quarterly Earnings on Thursday - MarketBeat
Organon & Co snaps six days of losses - MSN
Bleakley Financial Group LLC Purchases 36,367 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Optimist Retirement Group LLC Decreases Position in Organon & Co. (NYSE:OGN) - MarketBeat
Private Management Group Inc. Buys 225,420 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Robeco Institutional Asset Management B.V. Purchases New Position in Organon & Co. (NYSE:OGN) - MarketBeat
Why Organon (OGN) Dipped More Than Broader Market Today - Nasdaq
Sippican Capital Advisors Purchases 21,122 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Position Lessened by Exchange Traded Concepts LLC - MarketBeat
Nisa Investment Advisors LLC Trims Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN) Rises Higher Than Market: Key Facts - Yahoo Finance
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health - br.ADVFN.com
An excellent week for Organon & Co.'s (NYSE:OGN) institutional owners who own 83% as one-year returns inch higher - Yahoo Finance
OGNOrganon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy - br.ADVFN.com
Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation - br.ADVFN.com
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Organon & Co. (NYSE:OGN) Shares Purchased by Pacer Advisors Inc. - MarketBeat
DGS Capital Management LLC Acquires New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Sound Income Strategies LLC Acquires 39,726 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
With 79% ownership, Organon & Co. (NYSE:OGN) boasts of strong institutional backing - Simply Wall St
Organon announces departure of chief commercial officer - MSN
Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025 - Business Wire
Organon Sets Q4 2024 Earnings Date, Confirms No Milestone Expenses Expected - StockTitan
Organon announces departure of chief commercial officer By Investing.com - Investing.com South Africa
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Organon Announces Cessation of Chief Commercial Officer Role - TipRanks
Organon & Co. (NYSE:OGN) Stock Holdings Lessened by Gilman Hill Asset Management LLC - MarketBeat
Organon & Co. (NYSE:OGN) Upgraded by TD Cowen to Hold Rating - MarketBeat
Why Is Women Health-Focused Organon Stock Trading Higher On Thursday? - MSN
Organon: A Tricky 2025 Awaits, But I'm Happy With A >7% Dividend Yield (OGN) - Seeking Alpha
(OGN) Investment Analysis - Stock Traders Daily
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Organon & Co. set to break its six-day losing streak - MSN
TD Cowen holds Organon stock with $19 target, eyes 2025 outlook - Investing.com Australia
TD Cowen holds Organon stock with $19 target, eyes 2025 outlook By Investing.com - Investing.com South Africa
Organon snaps six days of winning streak - MSN
Wedmont Private Capital Grows Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):